Plan to increase Sputnik V vaccine production to 850 million doses per year in India: sent from Russia | India News
Nikolay Kudashev said on Saturday that local production is about to start soon and it is planned to gradually increase to 850 million doses per year.
Earlier today, a flight with the first batch of Russian vaccines landed in Hyderabad, Telangana. “Happy to share that the first batch of Sputnik V The vaccine was delivered today in Hyderabad! While Russia and India remain dedicated
Joint efforts to combat # COVID19, this measure is especially important to support the Indian government’s efforts to mitigate the second deadly wave and save lives, “said Ambassador Kudashev.
The efficacy of @sputnikvaccine is among the highest in the world, and this vaccine will also be effective against… https://t.co/Rzc9ApaD42
– Nikolay Kudashev 🇷🇺 (@NKudashev) 1619868193000
The Russian envoy also said that the efficacy of Sputnik V is among the highest in the world, and this vaccine will also be effective against new strains of Covid-19, “Its local production is about to start soon and is planned to be
gradually increased to 850 million doses per year. We look forward to further expanding our bilateral and multilateral cooperation with India to stop the pandemic, “he added.
Last month, the Comptroller General of Drugs (DCGI) had granted permission to Dr. Reddy’s Laboratories to import the Russian vaccine to India for emergency use.
The launch of the Russian vaccine is expected to augment the third phase of India’s vaccination campaign that began today amid a record surge in Covid-19 cases.
India, for the first time, has reported more than 4 lakh of new Covid-19 cases in the last 24 hours. A total of 4.01,993 new cases of Covid-19 were registered in the last 24 hours, bringing the cumulative count of cases to 18.104.22.1689, the Union Ministry of Health reported on Saturday.
Sputnik V is the third vaccine to which India has given the green light after ‘Covishield’, developed by Oxford University and AstraZeneca and ‘Covaxin’, the indigenous vaccine manufactured by Bharat Biotech. Covishield It is manufactured by the Serum Institute of India. Diplomatic sources had told ANI that India will receive a substantial quantity of vaccines in the first tranche and the supply will continue in installments. India expects 5 million vials of Sputnik vaccines for